Phase 4
Completed N=241
Evaluation of Reader Training Processes
Source: ClinicalTrials.gov NCT02051790 ↗Enrolled (actual)
241
Serious AEs
—
Results posted
Sep 2015
Primary outcomePrimary: Agreement Between Expert Panel and Clinical Practice Reads — 0.745 Weighted Kappa statistic
Summary
This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Agreement Between Expert Panel and Clinical Practice Reads |
0.745 | — |
Eligibility Criteria
Inclusion Criteria
- Scan obtained for clinical reasons
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT02051790). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.